期刊文献+

应用统计学方法设计培养基提高雷帕霉素发酵水平 被引量:1

Statistical experimental methods to design medium applied for improving the titer of rapamycin fermentation
下载PDF
导出
摘要 目的提高吸水链霉菌FC904-33发酵合成雷帕霉素水平。方法应用统计学方法设计培养基,首先利用Plackettburman设计法分析出培养基中影响雷帕霉素发酵水平的四个主要因素:玉米淀粉、葡萄糖、黄豆饼粉和蛋白胨;其次以Boxbehnken设计法及响应面分析法。结果确定了主要因素的最佳浓度:玉米淀粉37.25g/L,葡萄糖5.97g/L,黄豆饼粉29.54g/L,蛋白胨4.56g/L。结论采用统计学优化后培养基进行雷帕霉素发酵,发酵水平较原培养基提高了27%,达到预期效果。 Objective To improve the titer ofrapamycin production by Streptomyces hygroscopicus FC904-33. Methods Fermentation medium were designed by Statistical experimental methods. In the first step of optimization, Four nutritional factors that influenced the titer of rapamycin most significantly were screened out by Plackett- burman experimental design, and then optimized by Box-behnken factorial design and response surface methodology. Results The maximum rapamyein titer was predicted in the medium containing cornstarch 37.25g/L, glucose 5.97g/L, soybean cake powder 29.54g/L and yeast powder 4.56g/L. Conclusion Compared to the original medium, the titer of rapamycin in the optimized medium were increased by 27%.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2014年第12期901-904,共4页 Chinese Journal of Antibiotics
关键词 雷帕霉素 PLACKETT-BURMAN设计 BOX-BEHNKEN设计 响应面法 发酵培养基 Rapamycin Titer Plackett-burman design Box-behnken design Response surface methodology
  • 相关文献

参考文献9

  • 1程元荣.新型强效免疫抑制剂—西罗莫司[M]//王浴生主编.化疗药理学与临床研究新进展.成都:四川大学出版社,2002; 220-225.
  • 2Caccamo A,Majumder S,Deng J,et al.Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability[J].J Biol Chem,.2009,284(40):27416-27424.
  • 3Mabuchi S,DA A,Cheung M,et al.RAD001 inhibits human ovarian cancer cell proliferation,enhances cisplatininduced apoptosis and prolongs survival in an ovarian cancer model[J].Clin CancerRes,2007,13(14):4261-4270.
  • 4Fasolo A,Sessa C.mTOR inhibitors in the treatment of cancer[J].Expert Opin Investig Drugs,2008,17(11):1717-1734.
  • 5程元荣,林文良,黄捷,陈磊,余辉,江红,庄净宇.新型强效免疫抑制剂西罗莫司F904的研究[J].中国抗生素杂志,2002,27(12):709-712. 被引量:20
  • 6黄捷,金东伟,余辉,程元荣.西罗莫司高产突变株FC904-33[J].中国抗生素杂志,2007,32(8):462-465. 被引量:7
  • 7Sadik Ali S,Bibhu Prasad P,Saleem J,et al.Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology[J].4ppl MicrobiolBiotechnol,2007,73(5):1054-1058.
  • 8Lewis G,Mathieu D,Phan-Tan-Luu R.Drug and pharmaceutical sciences-pharmaceutical experimental design[M].Inc.USA:Marcel Dekker,1999,92:79-149.
  • 9Ambati P,Ayyanna C.Optimizing medium constituents and fermentation conditions for citric acid production from Palmyra jaggery using response surface method[J].World J Microbiol Biolotechnol,2001,17(4):331-335.

二级参考文献8

  • 1程元荣,郑卫.新分子靶位mTOR与新抗肿瘤靶向药物雷帕霉素[J].中国处方药,2006,5(12):16-19. 被引量:12
  • 2赵长春 王庭桂 等.临床免疫检验学[M].天津:天津科学技术出版社,1990.350.
  • 3程元荣.新型强效免疫抑制剂--雷帕霉素[A].王浴生.化疗药理学与临床研究新进展[M].成都:四川大学出版社,2002.220.
  • 4Fang A,Wong G K,Demain A L.Enhancement of the antifungal activity of rapamycin by the coproduced elaiophylin and nigericin[J].J Anbiot,2000,53(2):158.
  • 5Cheng Y R,Huang J,Qiang H,et al.Mutagenesis of the rapamycin producer Streptomyces hygroscopicus FC904[J].J Anbiot,2001,54(11):967.
  • 6Ford L M,Eaton T E,Godfrey O W.Selection of Streptomyces ambofaciens mutants that produce large quantities of spiramycin and determination of optimal conditions for spiramycin production[J].Appl Enviro Microbiol,1990,56(11):3511.
  • 7黄捷,金东伟,郑专,程元荣.雷帕霉素生物效价测定初步研究[J].海峡药学,1999,11(1):22-24. 被引量:2
  • 8程元荣,林文良,黄捷,陈磊,余辉,江红,庄净宇.新型强效免疫抑制剂西罗莫司F904的研究[J].中国抗生素杂志,2002,27(12):709-712. 被引量:20

共引文献20

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部